Journal Articles

A patented formulation of SiO2 – + Ag+ + Chlorhexidine + Hyaluronic acid

Share this article

A patented formulation of SiO2 – + Ag+ + Chlorhexidine + Hyaluronic acid

Harikrishna KR Nair, Nur Zati Ilwani
9 October 2019

In the management of chronic wounds, some of the important objectives include reduction of wound size and elimination of infection signs and pain management (Malaysian Ministry of Health [MOH], 2014). Most wound dressings are not able to support wound healing with a single product or therapy, hence, the introduction of a new formulation (Nair, 2017). To demonstrate its efficacy, nine patients were chosen which involved five cases of diabetic foot ulcer and four cases of venous leg ulcer. All wounds were cleaned and debrided where necessary, then a patented combination technology of SiO2 – + Ag+ + Chlorhexidine + Hyaluronic acid was applied as the primary dressing, with a non-adherent dressing as a secondary dressing. In cases where patients had exudating wounds, a pressure ulcer foam was added. The results of this case series demonstrated that it is possible for a single formulation to effectively support wound healing by reducing wound size and pain and eliminating infection signs.

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.